Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: Presumptive evidence for an interaction between vitamins C and E in vivo

American Journal of Clinical Nutrition

Volumn 67, Issue 2, 1998, Pages 240-245

  Harats, Dror ^b   Chevion, Shlomit ^b   Nahir, Menahem ^b   Norman, Yehudit ^b   Sagee, Oded ^b   Berry, Elliot M ^a  

^a HEBREW UNIVERSITY   (Israel)

^b NONE

Author keywords

Antioxidant; Ascorbic acid; Cardiovascular risk; Citrus fruit; Fibrinogen; Lipoprotein oxidation; Low density lipoprotein; Men; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; SATURATED FATTY ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CITRUS FRUIT; DIET SUPPLEMENTATION; HUMAN; HUMAN EXPERIMENT; LIPID DIET; LIPID OXIDATION; MALE; NORMAL HUMAN;

CITRUS;

EID: 0031910168     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.2.240     Document Type: Article

References (48)

1. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma, Proc Natl Acad Sci USA 1991;88: 11003-6.
2. Sies H, Stahl W. Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995;62(suppl): 1315S-21S.
3. Bielski BHJ, Richter HW. Some properties of the ascorbate free radical. Ann N Y Acad Sci 1975;258:231-7.
4. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53(suppl):326S-34S.
5. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in a cohort of elderly people. Br Med J 1995;310:1563-6.
6. Gey KF, Stahelin HB, Eicholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 1993;71:3-6.
7. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A,C and E and carotene. Lancet 1991;337:1-5.
8. Khaw KT, Woodhouse P. Interrelation of vitamin C, infection, hemostatic factors and cardiovascular disease. Br Med J 1995;310:1559-63.
9. Trout DL. Vitamin C and cardiovascular risk factors. Am J Clin Nutr 1991;53(suppl):322S-5S.
10. Hennekens CH, Gaziano JM, Manson JE, Buring JE. Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: the need for randomized trials. Am J Clin Nutr 1995;62(suppl):1377S-80S.
11. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and risk of coronary heart disease among men. N Engl J Med 1993;328:1450-6.
12. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Effect of vitamin C and E on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
13. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
14. Berry EM, Eisenberg S, Friedlander Y, et al. The effects of diets rich in monounsaturated fatty acids on plasma lipoproteins: the Jerusalem Nutrition Study: monounsaturated versus saturated fatty acids. Nutr Metab Cardiovasc Dis 1995;5:55-62.
15. Berry EM, Eisenberg S, Harats D, et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991:53:899-907.
16. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990;82:185-91.
17. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54(suppl):1113S-8S.
18. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
19. Friedewald W, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Esterbauer H, Strigel G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
21. Harats D, Dabach Y, Hollander G, et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins; attenuating effect of vitamin E. Atherosclerosis 1991;90: 127-39.
22. Motchnik PA, Frei B, Ames BN. Measurement of antioxidants in human blood plasma. Methods Enzymol 1994;234:269-79.
23. Rossi E, Mondonico P, Lombardi A, Oreda L. A method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulomers. Thromb Res 1988;52:453-68.
24. Koller F, Loeliger A, Duckert F. Physiology and pathology of blood coagulation. Acta Haematol 1951;6:178-91.
25. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996;119:139-50.
26. Packer L. Interactions among antioxidants in health and disease: vitamin E and its redox cycle. Proc Soc Exp Biol Med 1992: 200:271-6.
27. Ginter E, Cerna O, Budloversusky J, et al. Effect of ascorbic acid on plasma cholesterol in a long-term experiment. Int J Vitam Nutr Res 1977;47:123-34.
28. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11:107-25.
29. Johnson GE, Obenshain SS. Nonresponsiveness of serum high-density lipoprotein-cholesterol to high dose ascorbic acid administration in normal men. Am J Clin Nutr 1981;34:2088-91.
30. Peterson VE, Crapo PA, Weininger J, Ginsberg H, Olefsky J. Quantification of plasma cholesterol and triglyceride levels in hypercholesterolemic subjects receiving ascorbic acid supplements. Am J Clin Nutr 1975;28:584-7.
31. Khan AR, Seedarnee FA. Effects of ascorbic acid on plasma lipids and lipoproteins in healthy young women. Atherosclerosis 1981;39:89-95.
32. Greco AM, La Rocca L. Correlation between chronic hypovitaminosis C in old age and plasma levels of cholesterol and triglycerides. Int J Vitam Nutr Res Suppl 1982;23:129-36.
33. Bates CJ, Mandal AR, Cole TJ. HDL cholesterol and vitamin C status. Lancet 1977;2:611 (letter).
34. Yoshioka M, Matsushita T, Chuman Y. Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30-39 years. Int J Vitam Nutr Res 1984;54:343-7.
35. Todd S, Woodward M, Bolton-Smith C. An investigation of the relationship between antioxidant vitamin intake and coronary heart disease in men and women using logistic regression analysis. J Clin Epidemiol 1995;48:307-16.
36. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
37. Davies JD, Newson J. Ascorbic acid and cholesterol levels in pastoral peoples in Kenya, Am J Clin Nutr 1974;27:1039-42.
38. Ginter E. Chronic marginal vitamin C deficiency: biochemistry and patho-physiology. World Rev Nutr Diet 1979;33:104-41.
39. Ginter E, Kajaba I, Nizner O. The effect of ascorbic acid on cholesterolemia in healthy subjects with seasonal deficit of vitamin C. Nutr Metab 1970;12:76-86.
40. Paolisso G, Balbi V, Volpe C, et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non insulin dependent diabetics. J Am Coll Nutr 1995;14:387-92.
41. Margolis SA, Ziegler RG, Helzlsouer RG. Ascorbic and dehydroascorbic acid measurement in human serum and plasma. Am J Clin Nutr 1991;54(suppl):1315S-8S.
42. Gey KF, Moser UK, Jordan P, Stahelin HB, Eicholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57(suppl):787S-97S.
43. Levine M, Dhariwal KR, Welch RW, Wang Y, Park JB. Determination of optimal vitamin C requirements in humans. Am J Clin Nutr 1995;62(suppl):1347S-56S.
44. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989:115-24.
45. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health 1986;76:287-90.
46. Eaton SB, Konner M. Paleolithic nutrition. N Engl J Med 1985;312:283-9.
47. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215-8.
48. Baker EM, Saari JC, Tolbert BM. Ascorbic acid metabolism in man. Am J Clin Nutr 1966;19:371-8.